...
首页> 外文期刊>Medicina (Buenos Aires) >Premalignant quiescent melanocytic nevi do not express the MHC class I chain-related protein A
【24h】

Premalignant quiescent melanocytic nevi do not express the MHC class I chain-related protein A

机译:癌前静态黑素细胞痣不表达MHC I类链相关蛋白A

获取原文
           

摘要

The MHC class I chain-related protein A (MICA) is an inducible molecule almost not expressed by normal cells but strongly up-regulated in tumor cells. MICA-expressing cells are recognized by natural killer (NK) cells, CD8+ a?TCR and ?dTCR T lymphocytes through the NKG2D receptor. Engagement of NKG2D by MICA triggers IFN-? secretion and cytotoxicity against malignant cells. Although most solid tumors express MICA and this molecule is a target during immune surveillance against tumors, it has been observed that high grade tumors from different histotypes express low amounts of cell surface MICA due to a metalloprotease- induced shedding. Also, melanomas develop after a complex process of neotransformation of normal melanocytes. However, the expression of MICA in premalignant stages (primary human quiescent melanocytic nevi) remains unknown. Here, we assessed expression of MICA by flow cytometry using cell suspensions from 15 primary nevi isolated from 11 patients. When collected material was abundant, cell lysates were prepared and MICA expression was also analyzed by Western blot. We observed that MICA was undetectable in the 15 primary nevi (intradermic, junction, mixed, lentigo and congenital samples) as well as in normal skin, benign lesions (seborrheic keratosis), premalignant lesions (actinic keratosis) and benign basocellular cancer. Conversely, a primary recently diagnosed melanoma showed intense cell surface MICA. We conclude that the onset of MICA expression is a tightly regulated process that occurs after melanocytes trespass the stage of malignant transformation. Thus, analysis of MICA expression in tissue sections of skin samples may constitute a useful marker to differentiate between benign and malignant nevi.
机译:MHC I类链相关蛋白A(MICA)是一种诱导性分子,几乎不由正常细胞表达,但在肿瘤细胞中强烈上调。表达MICA的细胞通过NKG2D受体被自然杀伤(NK)细胞,CD8 +α?TCR和?dTCR T淋巴细胞识别。 MICA与NKG2D的结合会触发IFN-α。对恶性细胞的分泌和细胞毒性。尽管大多数实体瘤表达MICA,并且该分子是针对肿瘤的免疫监视过程中的靶标,但是已经观察到,由于金属蛋白酶诱导的脱落,来自不同组织型的高等级肿瘤表达了少量的细胞表面MICA。而且,黑色素瘤在正常黑色素细胞的新转化的复杂过程之后发展。然而,MICA在癌前期(原代人类静止的黑素细胞痣)的表达仍然未知。在这里,我们使用从11例患者中分离出的15例原发性痣的细胞悬液,通过流式细胞术评估了MICA的表达。当收集的物质丰富时,制备细胞裂解物,并通过蛋白质印迹分析MICA的表达。我们观察到在15例原发性痣(皮内,交界处,混合,扁桃体和先天性样本)以及正常皮肤,良性病变(脂溢性角化病),恶变前病变(光化性角化病)和良性基底细胞癌中均未检测到MICA。相反,最近被诊断出的原发性黑色素瘤表现出强烈的细胞表面MICA。我们得出结论,MICA表达的开始是一个严格调控的过程,发生在黑素细胞侵入恶性转化阶段之后。因此,分析皮肤样品的组织切片中的MICA表达可以构成区分良性和恶性痣的有用标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号